Tirzepatide emerges a groundbreaking treatment agent for individuals battling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://lucdrvz847422.develop-blog.com/48389702/tirzepatide-a-novel-glp-1-and-gip-receptor-agonist